Bruce A. Perkins
Bruce A. Perkins
Professor of Medicine, Endocrinology and Metabolism, University of Toronto
Verified email at - Homepage
Cited by
Cited by
Renal hemodynamic effect of sodium-glucose co-transporter 2 inhibition in patients with type 1 diabetes mellitus
DZ Cherney, BA Perkins, NCPA Soleymanlou, M Maione, V Lai, A Lee, ...
Circulation 129 (5), 587-97, 2014
Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications
HJL Heerspink, BA Perkins, DH Fitchett, M Husain, DZI Cherney
Circulation 134 (10), 752-772, 2016
Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes
RM Bergenstal, WV Tamborlane, A Ahmann, JB Buse, G Dailey, SN Davis, ...
New England Journal of Medicine 363 (4), 311-320, 2010
Regression of microalbuminuria in type 1 diabetes
BA Perkins, LH Ficociello, KH Silva, DM Finkelstein, JH Warram, ...
New England Journal of Medicine 348 (23), 2285-2293, 2003
Simple screening tests for peripheral neuropathy in the diabetes clinic
BA Perkins, D Olaleye, B Zinman, V Bril
Diabetes care 24 (2), 250-256, 2001
Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic …
V Bril, J England, GM Franklin, M Backonja, J Cohen, D Del Toro, ...
Pm&r 3 (4), 345-352. e21, 2011
Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy
V Bril, BA Perkins
Diabetes care 25 (11), 2048-2052, 2002
Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management
S Tesfaye, L Vileikyte, G Rayman, SH Sindrup, BA Perkins, M Baconja, ...
Diabetes/metabolism research and reviews 27 (7), 629-638, 2011
The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus
DZI Cherney, BA Perkins, N Soleymanlou, R Har, N Fagan, OE Johansen, ...
Cardiovascular diabetology 13, 1-8, 2014
Association of vitamin D with insulin resistance and β-cell dysfunction in subjects at risk for type 2 diabetes
S Kayaniyil, R Vieth, R Retnakaran, JA Knight, Y Qi, HC Gerstein, ...
Diabetes care 33 (6), 1379-1381, 2010
Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up …
BA Perkins, RG Nelson, BEP Ostrander, KL Blouch, AS Krolewski, ...
Journal of the American Society of Nephrology 16 (5), 1404-1412, 2005
Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes
BA Perkins, LH Ficociello, BE Ostrander, KH Silva, J Weinberg, ...
Journal of the American Society of Nephrology 18 (4), 1353-1361, 2007
Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials
A Weisman, JW Bai, M Cardinez, CK Kramer, BA Perkins
The lancet Diabetes & endocrinology 5 (7), 501-512, 2017
Carpal tunnel syndrome in patients with diabetic polyneuropathy
BA Perkins, D Olaleye, V Bril
Diabetes Care 25 (3), 565-569, 2002
In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria
BA Perkins, LH Ficociello, B Roshan, JH Warram, AS Krolewski
Kidney international 77 (1), 57-64, 2010
Resistance versus aerobic exercise: acute effects on glycemia in type 1 diabetes
JE Yardley, GP Kenny, BA Perkins, MC Riddell, N Balaa, J Malcolm, ...
Diabetes care 36 (3), 537-542, 2013
Empagliflozin as adjunctive to insulin therapy in type 1 diabetes: the EASE trials
J Rosenstock, J Marquard, LM Laffel, D Neubacher, S Kaspers, ...
Diabetes care 41 (12), 2560-2569, 2018
Effects of performing resistance exercise before versus after aerobic exercise on glycemia in type 1 diabetes
JE Yardley, GP Kenny, BA Perkins, MC Riddell, J Malcolm, P Boulay, ...
Diabetes care 35 (4), 669-675, 2012
Serum urate lowering with allopurinol and kidney function in type 1 diabetes
A Doria, AT Galecki, C Spino, R Pop-Busui, DZ Cherney, I Lingvay, ...
New England Journal of Medicine 382 (26), 2493-2503, 2020
Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial
BA Perkins, DZI Cherney, H Partridge, N Soleymanlou, H Tschirhart, ...
Diabetes care 37 (5), 1480-1483, 2014
The system can't perform the operation now. Try again later.
Articles 1–20